Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.

Liu Q, Chen MX, Sun L, Wallis CU, Zhou JS, Ao LJ, Li Q, Sham PC.

World J Stem Cells. 2019 Feb 26;11(2):55-72. doi: 10.4252/wjsc.v11.i2.55. Review.

2.

Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders.

Perets N, Betzer O, Shapira R, Brenstein S, Angel A, Sadan T, Ashery U, Popovtzer R, Offen D.

Nano Lett. 2019 Feb 27. doi: 10.1021/acs.nanolett.8b04148. [Epub ahead of print]

PMID:
30761901
3.

Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice.

Perets N, Hertz S, London M, Offen D.

Mol Autism. 2018 Nov 21;9:57. doi: 10.1186/s13229-018-0240-6. eCollection 2018.

4.

Zika Virus Infection of Human Mesenchymal Stem Cells Promotes Differential Expression of Proteins Linked to Several Neurological Diseases.

Beys-da-Silva WO, Rosa RL, Santi L, Berger M, Park SK, Campos AR, Terraciano P, Varela APM, Teixeira TF, Roehe PM, Quincozes-Santos A, Yates JR 3rd, Souza DO, Cirne-Lima EO, Guimarães JA.

Mol Neurobiol. 2018 Oct 30. doi: 10.1007/s12035-018-1417-x. [Epub ahead of print]

PMID:
30377986
5.

Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of children with autism spectrum disorder.

Nguyen HTN, Kato H, Masuda K, Yamaza H, Hirofuji Y, Sato H, Pham TTM, Takayama F, Sakai Y, Ohga S, Taguchi T, Nonaka K.

Biochem Biophys Rep. 2018 Sep 21;16:24-31. doi: 10.1016/j.bbrep.2018.09.004. eCollection 2018 Dec.

6.

Neural Progenitor Cell Polarity and Cortical Development.

Arai Y, Taverna E.

Front Cell Neurosci. 2017 Dec 5;11:384. doi: 10.3389/fncel.2017.00384. eCollection 2017.

7.

Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autism.

Perets N, Segal-Gavish H, Gothelf Y, Barzilay R, Barhum Y, Abramov N, Hertz S, Morozov D, London M, Offen D.

Behav Brain Res. 2017 Jul 28;331:254-260. doi: 10.1016/j.bbr.2017.03.047. Epub 2017 Apr 7.

PMID:
28392323
8.

Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.

Nitkin CR, Bonfield TL.

Stem Cells Transl Med. 2017 Feb;6(2):539-565. doi: 10.5966/sctm.2015-0427. Epub 2016 Sep 13.

9.

Retraction RETRACTION of two articles with plagiarism in common.

A M Duarte F.

Genet Mol Res. 2016 Oct 7;15(4). doi: 10.4238/gmr.1504004.

PMID:
27808396
10.

Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model.

Ha S, Park H, Mahmood U, Ra JC, Suh YH, Chang KA.

Behav Brain Res. 2017 Jan 15;317:479-484. doi: 10.1016/j.bbr.2016.10.004. Epub 2016 Oct 4.

PMID:
27717813
11.
12.

Prenatal β-catenin/Brn2/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors.

Belinson H, Nakatani J, Babineau BA, Birnbaum RY, Ellegood J, Bershteyn M, McEvilly RJ, Long JM, Willert K, Klein OD, Ahituv N, Lerch JP, Rosenfeld MG, Wynshaw-Boris A.

Mol Psychiatry. 2016 Oct;21(10):1417-33. doi: 10.1038/mp.2015.207. Epub 2016 Feb 2.

13.

Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice.

Segal-Gavish H, Karvat G, Barak N, Barzilay R, Ganz J, Edry L, Aharony I, Offen D, Kimchi T.

Autism Res. 2016 Jan;9(1):17-32. doi: 10.1002/aur.1530. Epub 2015 Aug 10.

PMID:
26257137
14.

Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises.

Simberlund J, Ferretti CJ, Hollander E.

World J Biol Psychiatry. 2015 Sep;16(6):368-375. doi: 10.3109/15622975.2015.1067372. Epub 2015 Jul 31.

PMID:
26230216
15.

Therapeutic properties of mesenchymal stem cells for autism spectrum disorders.

Gesundheit B, Ashwood P, Keating A, Naor D, Melamed M, Rosenzweig JP.

Med Hypotheses. 2015 Mar;84(3):169-77. doi: 10.1016/j.mehy.2014.12.016. Epub 2014 Dec 30.

PMID:
25592283
16.

Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.

Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, Siniscalco D.

Cell Transplant. 2014;23 Suppl 1:S105-12. doi: 10.3727/096368914X684916. Epub 2014 Oct 9.

PMID:
25302490
17.

Mesenchymal stem cells in treating autism: Novel insights.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

World J Stem Cells. 2014 Apr 26;6(2):173-8. doi: 10.4252/wjsc.v6.i2.173. Review.

18.

Progress of mesenchymal stem cell therapy for neural and retinal diseases.

Ng TK, Fortino VR, Pelaez D, Cheung HS.

World J Stem Cells. 2014 Apr 26;6(2):111-9. doi: 10.4252/wjsc.v6.i2.111. Review.

19.

Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism.

Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, Huan Y, Ge RC, Chen XW, Wang ZJ, Kim BJ, Hu X.

J Transl Med. 2013 Aug 27;11:196. doi: 10.1186/1479-5876-11-196.

20.

Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N.

J Biomed Biotechnol. 2012;2012:480289. doi: 10.1155/2012/480289. Epub 2012 Feb 13. Review.

Supplemental Content

Loading ...
Support Center